255 related articles for article (PubMed ID: 10540180)
1. Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.
Van Der Heijden JH; De Bruin TW; Glaudemans KA; De Kruif J; Banga JP; Logtenberg T
Clin Exp Immunol; 1999 Nov; 118(2):205-12. PubMed ID: 10540180
[TBL] [Abstract][Full Text] [Related]
2. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
[TBL] [Abstract][Full Text] [Related]
3. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
4. Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies.
Morgenthaler NG; Tremble J; Huang G; Scherbaum WA; McGregor AM; Banga JP
J Clin Endocrinol Metab; 1996 Feb; 81(2):700-6. PubMed ID: 8636291
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the antibody response to the extracellular region of recombinant thyrotropin receptor.
Morgenthaler NG; Kim MR; Gardas A; Vlase H; Aust G; Gupta M; McGregor AM; Banga JP
Autoimmunity; 1997; 26(2):75-84. PubMed ID: 9546816
[TBL] [Abstract][Full Text] [Related]
6. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies.
Kosugi S; Akamizu T; Takai O; Prabhakar BS; Kohn LD
Thyroid; 1991; 1(4):321-30. PubMed ID: 1726785
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.
Nicholson LB; Vlase H; Graves P; Nilsson M; Molne J; Huang GC; Morgenthaler NG; Davies TF; McGregor AM; Banga JP
J Mol Endocrinol; 1996 Apr; 16(2):159-70. PubMed ID: 9156519
[TBL] [Abstract][Full Text] [Related]
8. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
9. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
11. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit.
Chazenbalk GD; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2004 Apr; 89(4):1788-93. PubMed ID: 15070946
[TBL] [Abstract][Full Text] [Related]
12. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.
Kosugi S; Ban T; Akamizu T; Kohn LD
Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
14. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule.
Sugawa H; Akamizu T; Kosugi S; Ueda Y; Ohta C; Okuda J; Mori T
Eur J Endocrinol; 1995 Sep; 133(3):283-93. PubMed ID: 7581943
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin receptor autoantibodies recognizing two different epitopes on the TSH receptor: lack of relationship to patient age, sex, and ophthalmopathy.
Jaume JC; Prummel MF; Wiersinga WM; McLachlan SM; Rapoport B
Thyroid; 1993; 3(4):291-5. PubMed ID: 7509670
[TBL] [Abstract][Full Text] [Related]
16. Affinity purification and diagnostic use of TSH receptor autoantibodies from human serum.
Morgenthaler NG; Minich WB; Willnich M; Bogusch T; Hollidt JM; Weglöhner W; Lenzner C; Bergmann A
Mol Cell Endocrinol; 2003 Dec; 212(1-2):73-9. PubMed ID: 14654252
[TBL] [Abstract][Full Text] [Related]
17. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
19. Insight into screening immunoglobulin gene combinatorial libraries in a phage display vector: a tale of two antibodies.
Kakinuma A; Portolano S; Chazenbalk G; Rapoport B; McLachlan SM
Autoimmunity; 1997; 25(2):73-84. PubMed ID: 9189008
[TBL] [Abstract][Full Text] [Related]
20. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
